$51.53
+0.0200 (+0.0388%)
At Close: Aug 04, 2026
GSK's (GSK) PD-1 Inhibitor Drug Meets Lung Cancer Study Goal
12:02pm, Thursday, 06'th Oct 2022
GSK's (GSK) mid-stage study, evaluating the combination of its cancer drug Jemperli with chemotherapy in non-small cell lung cancer, meets the primary endpoint of objective response rate.
GSK: Some Upside Likely
04:31am, Thursday, 06'th Oct 2022
GSK's price might have underwhelmed recently, but it's picking up now, calling for a closer look at it after a demerger with its consumer healthcare division last quarter. It's largely well placed to
GSK's Key Drugs to Drive Sales in a Sluggish Second Half
10:32am, Wednesday, 05'th Oct 2022
GSK's specialty products like Dovato, Nucala, Trelegy Ellipta, Shingrix are driving sales, making up for the lower sales of established drugs due to generic erosion.
This Is the Best Time to Buy These 7 Long-Term Dividend Stocks
01:27pm, Monday, 03'rd Oct 2022
With recent stock market weakness, look for long-term dividend stocks to buy. After failing to hold a rally that began in June 2022, the S&P 500 erased more than it gained by Sept.
Here is What to Know Beyond Why GSK PLC Sponsored ADR (GSK) is a Trending Stock
10:32am, Monday, 03'rd Oct 2022
Glaxo (GSK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
GSK board appointment is positive says broker but focus is on weak GBP, Zantac legals
11:58am, Tuesday, 27'th Sep 2022
The rise in GSK PLC (LSE:GSK, NYSE:GSK) shares on the reporting of a finance chief was probably more to do with the slide in sterling, than the market's excitement about the creation of an all-female
AstraZeneca, BAT, Ferguson, 4imprint and other exporters get double-benefit from sterling crash
09:54am, Tuesday, 27'th Sep 2022
As the pound crashed following Kwasi Kwarteng's quasi-infamous ‘mini' budget, many crafty currency speculators made a quick fortune, while savvy stock market investors are still mulling which compan
Hot Penny Stocks To Watch As The Stock Market Crash Continues
06:30pm, Monday, 26'th Sep 2022 PennyStocks
Hot penny stocks to add to your watch list this week. Is it time to buy?
The post Hot Penny Stocks To Watch As The Stock Market Crash Continues appeared first on Penny Stocks to Buy, Picks, News and I
GSK poaches Burberry CFO to complete rare all-female executive leadership team
04:58am, Monday, 26'th Sep 2022
GSK PLC (LSE:GSK, NYSE:GSK) poached Burberry Group PLC (LSE:BRBY)'s chief financial officer (CFO) Julie Brown to complete a rare but all-female executive leadership team. Brown will replace Iain Macka
GSK picks Burberry's Brown as first female CFO
02:06am, Monday, 26'th Sep 2022
GSK named luxury fashion brand Burberry's Julie Brown as its first ever female chief financial officer on Monday to succeed Iain Mackay, at a time when the British drugmaker is sharpening focus on its
GSK poaches Burberry CFO Julie Brown to create all-female top team - Sky News
12:35pm, Saturday, 24'th Sep 2022
British drugmaker GSK plc , has poached Burberry Group's finance chief to create a rare all-female executive leadership team, Sky News reported on Saturday.
Spero (SPRO) Skyrockets 168% on Licensing Deal With GSK
03:02pm, Friday, 23'rd Sep 2022 Zacks Investment Research
The exclusive licensing agreement with GSK will fund Spero's (SPRO) existing operations and extend its current cash runway beyond 2024.
Pharma Stock Roundup: EU Nod to AZN & RHHBY Drugs, FDA Updates for LLY & MRK
02:02pm, Friday, 23'rd Sep 2022 Zacks Investment Research
Roche's (RHHBY) eye drug, Vabysmo and AstraZeneca's (AZN) asthma drug Tezspire get approval in Europe. The FDA approves expanded use of Lilly's (LLY) cancer drug, Retevmo.
Reddit Penny Stocks to Watch as September Ends
10:00am, Friday, 23'rd Sep 2022 PennyStocks
Check these Reddit penny stocks out for your watchlist right now
The post Reddit Penny Stocks to Watch as September Ends appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
GSK (GSK) Gains As Market Dips: What You Should Know
09:50pm, Thursday, 22'nd Sep 2022 Zacks Investment Research
In the latest trading session, GSK (GSK) closed at $30.01, marking a +0.81% move from the previous day.
Sign In
Buy GSK